The use of new antiepileptic drugs

Journal of the Royal College of Physicians of London

Volumn 33, Issue 4, 1999, Pages 328-332

  Chadwick, David ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETHOSUXIMIDE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

APLASTIC ANEMIA; DEPRESSION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; HUMAN; ORAL DRUG ADMINISTRATION; PSYCHOSIS; SHORT SURVEY; SIDE EFFECT; SKIN MANIFESTATION; VISUAL IMPAIRMENT;

ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; HUMANS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0032842638     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (24)

1. White HS. Mechanisms of antiepileptic drugs. In: Porter RJ, Chadwick D (eds). The epilepsies 2. New York: Butterworth-Heinemann 1997:1-30.
2. Jacoby A, Buck D, Baker G, McNamee T, et al. Uptake and costs of care for epilepsy: findings from a UK regional study. Epilepsia 1998;39:776-86.
3. Mignot G. Drug trials in epilepsy. Br Med J 1996;313:1158.
4. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-80.
5. Elferink JA, Van Zwieten-Boot BJ. New antiepileptic drugs. Analysis based on number needed to treat shows differences between drugs studied. Br Med J 1997;314:603.
6. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 1995;345:476-9.
7. Reunanen M, Dam M, Yuen AW. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 1996;23:149-55.
8. Chadwick D, Roi L, Kennedy KM. Vigabatrin (Sabril) as a first-line monotherapy in newly diagnosed epilepsy: a double-blind comparison with carbamazepine. Epilepsia 1996;37:6.
9. Kalviainen R, Aikia M, Saukkonen AM, Mervaala E, Riekkinen PJ Sr. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized controlled study. Arch Neurol 1995;52:989-96.
10. Chadwick DW, Anhut H, Greiner MJ, Alexander MS, et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology 1998;51:1282-8.
11. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. Br Med J 1996;313:36-9.
12. Mattson RH, Cramer JA, Collins JF, Smith DB, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalised tonic-clonic seizures. N Engl J Med 1985;313:145-51.
13. Chiron C, Dulac O, Gram L. Vigabatrin withdrawal randomized study in children. Epilepsy Res 1996;25:209-15.
14. Vigevano F, Cilio MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized prospective study. Epilepsia 1997;38:1270-4.
15. Appleton RE (for The Infantile Spasm Study Group), Thornton L Double blind comparison of Vigabatrin versus placebo in newly diagnosed and previously untreated infantile spasms. Epilepsia 1996;37:125.
16. Felbamate Study Group. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
17. Motte J, Trevathan E, Arvidsson JFV, Barrera MN, et al. Lamotrigine for generalised seizures associated with the Lennox-Gastaut syndrome. The Lamictal Lennox-Gastaut Study Group. N Engl J Med 1997;337:1807-12.
18. Glauser TA. Preliminary observations on topiramate in paediatric epilepsies. Epilepsia 1997;38(Suppl 1):S37-41.
19. Stables JP, Bialer M, Johannessen SI, Kupferberg HJ, et al. Progress report on new antiepileptic drugs. A summary of the Second Eilat Conference. Epilepsy Res 1995;22:235-46.
20. Richens A. Vigabatrin and lamotrigine. In: Porter RJ, Chadwick D (eds). The epilepsies 2. New York: Butterworth-Heinemann 1997:201-22.
21. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. Br Med J 1997;314:180-1.
22. Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 1998;50:614-8.
23. Kalviainen R, Nousiainen I, Mantyjarvi M, Riekkinen PJ. Initial vigabatrin monotherapy is associated with increased risk of visual field constriction. Epilepsia 1998;39(Suppl 6):72.
24. Richens A, Perucca E. Clinical pharmacology and medical treatment. In: Laidlaw J, Richens A, Chadwick D (eds). A textbook of epilepsy. Edinburgh: Churchill Livingstone, 1993:495-560.